FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2090469340> ?p ?o ?g. }

• W2090469340 endingPage "167" @default.
• W2090469340 startingPage "163" @default.
• W2090469340 abstract "Compared to unfractionated heparin (UFH), bivalirudin decreases bleeding during percutaneous coronary interventions (PCIs). We sought to investigate the association between periprocedural bleeding and 1-year mortality as a function of antithrombotic therapy with bivalirudin or UFH. This analysis of the association between bleeding with bivalirudin or UFH and 1-year mortality included the 4,570 patients with negative biomarkers enrolled in the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT 3) trial. Major or minor bleeding occurred in 555 patients (12.1%): 225 patients treated with bivalirudin (9.8%) and 330 patients treated with UFH (14.5%, p <0.001). There were 82 deaths (1.8%) within the first year after PCI: 29 deaths occurred in patients who had bled, and 53 deaths occurred in patients who had not bled (Kaplan-Meier estimates of 1-year mortality 5.2% and 1.3%, odds ratio 4.12, 95% confidence interval 2.59 to 6.54, p <0.001). One year after PCI, there were 15 deaths in patients who bled with bivalirudin versus 14 deaths in patients who bled with UFH (Kaplan-Meier estimates of 1-year mortality 6.7% vs 4.2%, odds ratio 1.61, 95% confidence interval 0.76 to 3.40, p = 0.20). Major bleeding occurred in 70 patients (3.0%) treated with bivalirudin and 104 patients treated with UFH (4.5%, p = 0.008). One-year mortality was 11.4% (n = 8) in patients with major bleeding with bivalirudin versus 4.8% (n = 5) in patients with major bleeding with UFH (p = 0.10). In conclusion, these data suggest that in patients with negative biomarkers undergoing PCI, bivalirudin decreases bleeding after PCI compared to UFH, without affecting 1-year mortality in those who had bled. Compared to unfractionated heparin (UFH), bivalirudin decreases bleeding during percutaneous coronary interventions (PCIs). We sought to investigate the association between periprocedural bleeding and 1-year mortality as a function of antithrombotic therapy with bivalirudin or UFH. This analysis of the association between bleeding with bivalirudin or UFH and 1-year mortality included the 4,570 patients with negative biomarkers enrolled in the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT 3) trial. Major or minor bleeding occurred in 555 patients (12.1%): 225 patients treated with bivalirudin (9.8%) and 330 patients treated with UFH (14.5%, p <0.001). There were 82 deaths (1.8%) within the first year after PCI: 29 deaths occurred in patients who had bled, and 53 deaths occurred in patients who had not bled (Kaplan-Meier estimates of 1-year mortality 5.2% and 1.3%, odds ratio 4.12, 95% confidence interval 2.59 to 6.54, p <0.001). One year after PCI, there were 15 deaths in patients who bled with bivalirudin versus 14 deaths in patients who bled with UFH (Kaplan-Meier estimates of 1-year mortality 6.7% vs 4.2%, odds ratio 1.61, 95% confidence interval 0.76 to 3.40, p = 0.20). Major bleeding occurred in 70 patients (3.0%) treated with bivalirudin and 104 patients treated with UFH (4.5%, p = 0.008). One-year mortality was 11.4% (n = 8) in patients with major bleeding with bivalirudin versus 4.8% (n = 5) in patients with major bleeding with UFH (p = 0.10). In conclusion, these data suggest that in patients with negative biomarkers undergoing PCI, bivalirudin decreases bleeding after PCI compared to UFH, without affecting 1-year mortality in those who had bled." @default.
• W2090469340 created "2016-06-24" @default.
• W2090469340 creator A5007093669 @default.
• W2090469340 creator A5015669756 @default.
• W2090469340 creator A5028965875 @default.
• W2090469340 creator A5039515279 @default.
• W2090469340 creator A5050866716 @default.
• W2090469340 creator A5057580138 @default.
• W2090469340 creator A5059733088 @default.
• W2090469340 creator A5070212671 @default.
• W2090469340 creator A5078207171 @default.
• W2090469340 creator A5089531887 @default.
• W2090469340 creator A5090370545 @default.
• W2090469340 creator A5091183607 @default.
• W2090469340 date "2010-01-01" @default.
• W2090469340 modified "2023-10-18" @default.
• W2090469340 title "Bleeding After Percutaneous Coronary Intervention With Bivalirudin or Unfractionated Heparin and One-Year Mortality" @default.
• W2090469340 cites W1421247184 @default.
• W2090469340 cites W1573872903 @default.
• W2090469340 cites W1973543600 @default.
• W2090469340 cites W1979372622 @default.
• W2090469340 cites W1999841380 @default.
• W2090469340 cites W2006920433 @default.
• W2090469340 cites W2020353475 @default.
• W2090469340 cites W2030078522 @default.
• W2090469340 cites W2030271409 @default.
• W2090469340 cites W2045713748 @default.
• W2090469340 cites W2058635451 @default.
• W2090469340 cites W2099409915 @default.
• W2090469340 cites W2102296549 @default.
• W2090469340 cites W2104954036 @default.
• W2090469340 cites W2105608312 @default.
• W2090469340 cites W2109985467 @default.
• W2090469340 cites W2121251309 @default.
• W2090469340 cites W2156927593 @default.
• W2090469340 doi "https://doi.org/10.1016/j.amjcard.2009.08.668" @default.
• W2090469340 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20102912" @default.
• W2090469340 hasPublicationYear "2010" @default.
• W2090469340 type Work @default.
• W2090469340 sameAs 2090469340 @default.
• W2090469340 citedByCount "24" @default.
• W2090469340 countsByYear W20904693402013 @default.
• W2090469340 countsByYear W20904693402014 @default.
• W2090469340 countsByYear W20904693402015 @default.
• W2090469340 countsByYear W20904693402016 @default.
• W2090469340 countsByYear W20904693402017 @default.
• W2090469340 countsByYear W20904693402018 @default.
• W2090469340 countsByYear W20904693402022 @default.
• W2090469340 countsByYear W20904693402023 @default.
• W2090469340 crossrefType "journal-article" @default.
• W2090469340 hasAuthorship W2090469340A5007093669 @default.
• W2090469340 hasAuthorship W2090469340A5015669756 @default.
• W2090469340 hasAuthorship W2090469340A5028965875 @default.
• W2090469340 hasAuthorship W2090469340A5039515279 @default.
• W2090469340 hasAuthorship W2090469340A5050866716 @default.
• W2090469340 hasAuthorship W2090469340A5057580138 @default.
• W2090469340 hasAuthorship W2090469340A5059733088 @default.
• W2090469340 hasAuthorship W2090469340A5070212671 @default.
• W2090469340 hasAuthorship W2090469340A5078207171 @default.
• W2090469340 hasAuthorship W2090469340A5089531887 @default.
• W2090469340 hasAuthorship W2090469340A5090370545 @default.
• W2090469340 hasAuthorship W2090469340A5091183607 @default.
• W2090469340 hasConcept C126322002 @default.
• W2090469340 hasConcept C141071460 @default.
• W2090469340 hasConcept C156957248 @default.
• W2090469340 hasConcept C164705383 @default.
• W2090469340 hasConcept C2777015399 @default.
• W2090469340 hasConcept C2777565915 @default.
• W2090469340 hasConcept C2780400711 @default.
• W2090469340 hasConcept C44249647 @default.
• W2090469340 hasConcept C45393284 @default.
• W2090469340 hasConcept C500558357 @default.
• W2090469340 hasConcept C71924100 @default.
• W2090469340 hasConceptScore W2090469340C126322002 @default.
• W2090469340 hasConceptScore W2090469340C141071460 @default.
• W2090469340 hasConceptScore W2090469340C156957248 @default.
• W2090469340 hasConceptScore W2090469340C164705383 @default.
• W2090469340 hasConceptScore W2090469340C2777015399 @default.
• W2090469340 hasConceptScore W2090469340C2777565915 @default.
• W2090469340 hasConceptScore W2090469340C2780400711 @default.
• W2090469340 hasConceptScore W2090469340C44249647 @default.
• W2090469340 hasConceptScore W2090469340C45393284 @default.
• W2090469340 hasConceptScore W2090469340C500558357 @default.
• W2090469340 hasConceptScore W2090469340C71924100 @default.
• W2090469340 hasIssue "2" @default.
• W2090469340 hasLocation W20904693401 @default.
• W2090469340 hasLocation W20904693402 @default.
• W2090469340 hasOpenAccess W2090469340 @default.
• W2090469340 hasPrimaryLocation W20904693401 @default.
• W2090469340 hasRelatedWork W193640619 @default.
• W2090469340 hasRelatedWork W2127687375 @default.
• W2090469340 hasRelatedWork W2355614377 @default.
• W2090469340 hasRelatedWork W2375584960 @default.
• W2090469340 hasRelatedWork W2378890344 @default.
• W2090469340 hasRelatedWork W2782203991 @default.
• W2090469340 hasRelatedWork W3029377117 @default.
• W2090469340 hasRelatedWork W3029448752 @default.
• W2090469340 hasRelatedWork W4318064246 @default.

• next